Home > Healthcare > Medical Devices > Diagnostic Devices > Automated Immunoassay Analyzers Market

Automated Immunoassay Analyzers Market Share

Report ID: GMI1727
Published Date: May 2023
Report Format: PDF

Download Free Sample

Automated Immunoassay Analyzers Market Share

Few of the leading players operating in the automated immunoassay analyzers market include

F. Hoffmann-La Roche AG
Abbott Laboratories
BioMerieux
BioRad Laboratories
Perkin Elmer
Biokit
Luminex Corporation

The market is consolidated in nature, with leading players, regional and local companies, along with start-ups further consolidating the industry competition. The leading market players are involved in strategic developments including research and development, novel product launches, partnerships, to improve their market positioning and revenue generating capabilities.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The size of automated immunoassay analyzers industry was valued at USD 16.9 billion in 2022 and will reach over USD 67.7 billion in 2032, attributed to the growing prevalence of infectious illnesses, novel product launches, and growing range of clinical use of immunoassay analyzers.

The chemiluminescence segment was worth USD 5.3 billion in 2022 as a result of the high accuracy and sensitivity of the diagnosis using low analyte concentration.

The hospital end-use segment is anticipated to witness a 14.7% CAGR from 2023 to 2032 owing to the rising number of people suffering from heart and lung disorders, increasing awareness levels, and facilitative reimbursement schemes.

North America automated immunoassay analyzers market is predicted to reach over USD 23.2 billion by 2032 propelled by the increasing prevalence of infectious diseases, different allergies, and cancer in the region.